ZEB2 and ovarian serous carcinoma: Elgaaen et al. reported over-expression of miR-200 family and under expression of ZEB1, ZEB2 and vimentin in high-grade serous ovarian carcinoma (HGSC) and clear cell ovarian carcinoma (COC) which were further confirmed by Ingenuity pathway analysis (IPA) documenting ZEB1 and ZEB2 as the most under expressed mRNAs in HGSC compared to ovarian surface epithelium [20].